Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Maria Michelagnoli"'
Autor:
Maria Michelagnoli, Tim Briggs, Rob Pollock, Roberto Tirabosco, Anna Cassoni, Gurhan Erturan, Harriet Holme
Publikováno v:
Rare Tumors, Vol 4, Iss 3, Pp e38-e38 (2012)
Desmoid fibromatosis (DF) is a heterogeneous condition with lack of consensus regarding therapy. Fatality is rare but repeated surgery prevalent. Functional assessment for this group is not well established, although we believe it to be an important
Externí odkaz:
https://doaj.org/article/a33c87a7f825418081c616785000b9b2
Publikováno v:
Skeletal Radiology. 50:2415-2422
To determine whether skip metastases (SM) in high-grade appendicular osteosarcoma (HG-OS) are an indicator of more aggressive disease. Retrospective review of patients with histologically confirmed diagnosis HG-OS of the long bones from 2007 to 2020,
Publikováno v:
Skeletal Radiology. 50:1081-1093
Evaluating the extent of skeletal disease in Langerhans cell histiocytosis (LCH) is a major predictor of patient outcome. Traditionally, whole-body skeletal staging consists of plain radiography and bone scintigraphy. However, more recently whole-bod
Publikováno v:
Skeletal radiologyReferences.
To identify in appendicular Ewing sarcoma (ES), if skip metastases (SM) are associated with distant metastases at presentation, response to neoadjuvant chemotherapy and overall outcome.Patients with appendicular ES from 2007 to 2021 who had whole-bon
Autor:
Rachael Windsor, Anthony Hamilton, Anne McTiernan, Palma Dileo, Maria Michelagnoli, Beatrice Seddon, Sandra J. Strauss, Jeremy Whelan
Publikováno v:
European journal of cancer (Oxford, England : 1990). 170
outcome of primary refractory or recurrent Ewing sarcoma (RRES) is poor and the role of high-dose therapy (HDT) remains uncertain. We retrospectively reviewed all patients treated for RRES in the London Sarcoma Service (LSS) over a 22-year period wit
Autor:
Katrina M. Ingley, Maria Michelagnoli, Rachael Windsor, Stefan Vöö, Asif Saifuddin, Simon Wan, Sandra J. Strauss
Publikováno v:
Cancers
Cancers, Vol 13, Iss 3261, p 3261 (2021)
Cancers, Vol 13, Iss 3261, p 3261 (2021)
Simple Summary Ewing sarcoma (ES) is a rare primary bone cancer, usually found in children and adolescents, which can spread to the lungs, other bones and less commonly, the bone marrow. An accurate determination of the disease spread at baseline (st
Autor:
Beatrice Seddon, Joanna McDerra, Mahbubl Ahmed, Rachael Windsor, Marina Milic, Thomas J Carter, Jeremy Whelan, Sandra J. Strauss, Maria Michelagnoli, Palma Dileo, Anne McTiernan, Vasilios Karavasilis
Publikováno v:
Cancers
Volume 12
Issue 11
Cancers, Vol 12, Iss 3408, p 3408 (2020)
Volume 12
Issue 11
Cancers, Vol 12, Iss 3408, p 3408 (2020)
Ifosfamide is used to treat soft-tissue sarcoma (STS) and bone sarcoma (BS), with improved efficacy at doses above 9 g/m2/cycle. To mitigate treatment-associated toxicity with higher doses, continuous infusional ifosfamide is increasingly used. Howev
Autor:
Richard G. Feltbower, Michael Richards, Patricia A. McKinney, Maria Michelagnoli, Sally E. Kinsey, G Shenton
Publikováno v:
British Journal of Cancer
We examined population-based information on relapsed childhood haematological cancers, investigating factors that might influence both overall survival and survival following relapse among the 1177 children (0-14 years) diagnosed with a haematologica
Publikováno v:
Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses. 33(1)
Few validated tools are available in childhood cancers settings to assess distress and worry. Twenty-one young people (mean age = 14 years), with an average 4 years since diagnosis, attended a sarcoma follow-up clinic and were asked to complete quest
Publikováno v:
Annals of Oncology. 17:1301-1305
Background: The outcome for patients with recurrent or progressive Ewing's sarcoma family of tumours (ESFT) is poor. High dose therapy (HDT) has been used for a number of years in an attempt to improve survival; however, evidence for the efficacy of